These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 28734639)

  • 1. FFA4/GPR120: Pharmacology and Therapeutic Opportunities.
    Milligan G; Alvarez-Curto E; Hudson BD; Prihandoko R; Tobin AB
    Trends Pharmacol Sci; 2017 Sep; 38(9):809-821. PubMed ID: 28734639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing pharmacological ligands to study the long-chain fatty acid receptors GPR40/FFA1 and GPR120/FFA4.
    Milligan G; Alvarez-Curto E; Watterson KR; Ulven T; Hudson BD
    Br J Pharmacol; 2015 Jul; 172(13):3254-65. PubMed ID: 25131623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration of phenylpropanoic acids as agonists of the free fatty acid receptor 4 (FFA4): Identification of an orally efficacious FFA4 agonist.
    Sparks SM; Aquino C; Banker P; Collins JL; Cowan D; Diaz C; Dock ST; Hertzog DL; Liang X; Swiger ED; Yuen J; Chen G; Jayawickreme C; Moncol D; Nystrom C; Rash V; Rimele T; Roller S; Ross S
    Bioorg Med Chem Lett; 2017 Mar; 27(5):1278-1283. PubMed ID: 28148462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of dietary fatty acids on FFA1 and FFA4 and characterisation of pinolenic acid as a dual FFA1/FFA4 agonist with potential effect against metabolic diseases.
    Christiansen E; Watterson KR; Stocker CJ; Sokol E; Jenkins L; Simon K; Grundmann M; Petersen RK; Wargent ET; Hudson BD; Kostenis E; Ejsing CS; Cawthorne MA; Milligan G; Ulven T
    Br J Nutr; 2015 Jun; 113(11):1677-88. PubMed ID: 25916176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral administration of the selective GPR120/FFA4 agonist compound A is not effective in alleviating tissue inflammation in mouse models of prototypical autoimmune diseases.
    Wannick M; Bezdek S; Guillen N; Thieme M; Meshrkey F; Mousavi S; Seeling M; Nimmerjahn F; Mócsai A; Zillikens D; Sezin T; Sadik CD
    Pharmacol Res Perspect; 2018 Dec; 6(6):e00438. PubMed ID: 30455959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological Tool Compounds for the Free Fatty Acid Receptor 4 (FFA4/GPR120).
    Hansen SV; Ulven T
    Handb Exp Pharmacol; 2017; 236():33-56. PubMed ID: 27807695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism.
    Hudson BD; Shimpukade B; Mackenzie AE; Butcher AJ; Pediani JD; Christiansen E; Heathcote H; Tobin AB; Ulven T; Milligan G
    Mol Pharmacol; 2013 Nov; 84(5):710-25. PubMed ID: 23979972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120).
    Sparks SM; Chen G; Collins JL; Danger D; Dock ST; Jayawickreme C; Jenkinson S; Laudeman C; Leesnitzer MA; Liang X; Maloney P; McCoy DC; Moncol D; Rash V; Rimele T; Vulimiri P; Way JM; Ross S
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3100-3. PubMed ID: 24881566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probe-Dependent Negative Allosteric Modulators of the Long-Chain Free Fatty Acid Receptor FFA4.
    Watterson KR; Hansen SVF; Hudson BD; Alvarez-Curto E; Raihan SZ; Azevedo CMG; Martin G; Dunlop J; Yarwood SJ; Ulven T; Milligan G
    Mol Pharmacol; 2017 Jun; 91(6):630-641. PubMed ID: 28385906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and target-pathway deconvolution of FFA4 agonists with anti-diabetic activity from Arnebia euchroma (Royle) Johnst.
    Xu F; Wang P; Zhang X; Hou T; Qu L; Wang C; Wang J; Liu Y; Liang X
    Pharmacol Res; 2021 Jan; 163():105173. PubMed ID: 33027715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FFA4 (GPR120) as a fatty acid sensor involved in appetite control, insulin sensitivity and inflammation regulation.
    Im DS
    Mol Aspects Med; 2018 Dec; 64():92-108. PubMed ID: 28887275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FFA4 receptor (GPR120): A hot target for the development of anti-diabetic therapies.
    Liu HD; Wang WB; Xu ZG; Liu CH; He DF; Du LP; Li MY; Yu X; Sun JP
    Eur J Pharmacol; 2015 Sep; 763(Pt B):160-8. PubMed ID: 26123847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FFA4/GPR120 agonists: a survey of the recent patent literature.
    Formicola R; Pevarello P; Kuhn C; Liberati C; Piscitelli F; Sodano M
    Pharm Pat Anal; 2015; 4(6):443-51. PubMed ID: 26580993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Free Fatty Acid Receptor 4 (FFA4/GPR120) Agonists in Health Science.
    Son SE; Kim NJ; Im DS
    Biomol Ther (Seoul); 2021 Jan; 29(1):22-30. PubMed ID: 33372166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel FFA4 (GPR120) receptor agonists with β-arrestin2-biased characteristics.
    Li A; Yang D; Zhu M; Tsai KC; Xiao KH; Yu X; Sun J; Du L
    Future Med Chem; 2015; 7(18):2429-37. PubMed ID: 26653412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-3 fatty acids and other FFA4 agonists inhibit growth factor signaling in human prostate cancer cells.
    Liu Z; Hopkins MM; Zhang Z; Quisenberry CB; Fix LC; Galvan BM; Meier KE
    J Pharmacol Exp Ther; 2015 Feb; 352(2):380-94. PubMed ID: 25491146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functions of omega-3 fatty acids and FFA4 (GPR120) in macrophages.
    Im DS
    Eur J Pharmacol; 2016 Aug; 785():36-43. PubMed ID: 25987421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular basis of ligand interaction at free fatty acid receptor 4 (FFA4/GPR120).
    Hudson BD; Shimpukade B; Milligan G; Ulven T
    J Biol Chem; 2014 Jul; 289(29):20345-58. PubMed ID: 24860101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary Fatty Acids and Their Potential for Controlling Metabolic Diseases Through Activation of FFA4/GPR120.
    Ulven T; Christiansen E
    Annu Rev Nutr; 2015; 35():239-63. PubMed ID: 26185978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free fatty acid receptor 4 (FFA4) activation ameliorates 2,4-dinitrochlorobenzene-induced atopic dermatitis by increasing regulatory T cells in mice.
    Son SE; Park SJ; Koh JM; Im DS
    Acta Pharmacol Sin; 2020 Oct; 41(10):1337-1347. PubMed ID: 32555509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.